HCW Biologics Inc.
13F holders, Q4 2024 (December 31)18holders +2
4new positions
2sold out
1famous investor
$0.45avg. 13F price*
At the end of Q4 2024, 18 institutions reported holding HCW Biologics Inc. in their 13F filings, up 2 from Q3 2024. 4 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($903K), Avantax Planning Partners, Inc. ($125K) and Geode Capital Management, LLC ($81K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- HCW Biologics Inc.
- CUSIP
- 40423R105
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $932K |
| Exits | 2 | $28K |
All 13F filers, Q3 2024 → Q4 2024: 2,088,286 shares bought and 118,637 shares sold, net +1,969,649 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Armistice Capital, LLC | 0.02% | New | 2,023,664 | $903K |
| Avantax Planning Partners, Inc. | 0.00% | No change | 279,541 | $125K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.7% | 181,957 | $81K |
| HighTower Advisors, LLC | 0.00% | No change | 180,810 | $81K |
| Cresset Asset Management, LLC | 0.00% | No change | 131,990 | $59K |
| Pullen Investment Management, LLC | 0.02% | No change | 75,116 | $34K |
| BlackRock, Inc. | 0.00% | Reduce -3.1% | 42,989 | $19K |
| Vanguard Group Inc. | 0.00% | No change | 37,677 | $17K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -59.0% | 34,700 | $15K |
| XTX Topco Ltd | 0.00% | New | 33,999 | $15K |
| AE Wealth Management LLC | 0.00% | No change | 30,000 | $13K |
| State Street Corp. | 0.00% | No change | 21,446 | $10K |
| Virtu Financial LLC | 0.00% | New | 15,623 | $7K |
| Renaissance Technologies | 0.00% | New | 15,000 | $7K |
| Two Sigma Investments, LP | 0.00% | Reduce -46.2% | 12,082 | $5K |
| Northern Trust Corp. | 0.00% | No change | 10,205 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -69.6% | 1,787 | $797 |
| Bank of America Corp. | 0.00% | Reduce -56.9% | 146 | $65 |
"% of holder's portfolio" is HCW BIOLOGICS INC's weight in each manager's 13F, not the share of HCW Biologics Inc. the manager owns.